Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

S-Allylmercapto-N-acetylcysteine (ASSNAC) protects cultured nerve cells from oxidative stress and attenuates experimental autoimmune encephalomyelitis.
Specialty drug coupons lower out-of-pocket costs and may improve adherence at the risk of increasing premiums.
Myelin loss and axonal ion channel adaptations associated with gray matter neuronal hyperexcitability.
Pain-related mood influences pain perception differently in fibromyalgia and multiple sclerosis.
Point prevalence and correlates of depression in a national community sample with multiple sclerosis.
Deficient phosphorylation of stat1 in leukocytes identifies neutralizing antibodies in multiple sclerosis patients treated with interferon-Beta.
Stabilometric assessment of context dependent balance recovery in persons with multiple sclerosis: a randomized controlled study.
Olfactory Pathology in Central Nervous System Demyelinating Diseases.
ADC evaluation of the corticospinal tract in multiple sclerosis.
RP-CARS: label-free optical readout of the myelin intrinsic healthiness.
Reliability of Longitudinal Brain Volume Loss Measurements between 2 Sites in Patients with Multiple Sclerosis: Comparison of 7 Quantification Techniques.
Severe relapses under fingolimod treatment prescribed after natalizumab.
Multiple sclerosis: Repurposing dopaminergic drugs for MS - the evidence mounts.
Iron deposition in the precentral grey matter in patients with multiple sclerosis: A quantitative study using susceptibility-weighted imaging.
Enhancing Neural Transmission in Multiple Sclerosis (4-Aminopyridine Therapy).
Increased Plasma Interleukin-32 Expression in Patients with Neuromyelitis Optica.
Targeting cells in motion: migrating toward improved therapies.
Compromised motor imagery ability in individuals with multiple sclerosis and mild physical disability: An ERP study.
Human Mesenchymal Stem Cells Upregulate CD1dCD5(+) Regulatory B Cells in Experimental Autoimmune Encephalomyelitis.
Brainstem manifestations in neuromyelitis optica: a multicenter study of 258 patients.
Natalizumab reduces relapse clinical severity and improves relapse recovery in MS.
NMDA receptor antibodies associated with distinct white matter syndromes.
The relationship of age, function, and psychological distress in multiple sclerosis.
[Treatment of multiple sclerosis symptoms and exacerbations].
Ethical considerations when counseling patients about stem cell tourism.

Pages